Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 203,687 $ 68,615
Accounts receivable 12,215 35,378
Grant receivable 71,779 130,152
Prepaid expenses 56,745 82,765
Total current assets 344,426 316,910
Property and equipment, net 70,202 76,572
Right to use assets 240,102 270,406
Other assets:    
Patents, net 9,911 10,206
Software development costs 0 47,980
Deposits, long term 44,520 44,520
Total other assets 54,431 102,706
Total assets 709,161 766,594
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,217,110 and $1,077,088, respectively 4,151,656 3,907,954
Deferred revenue, short term 24,630 33,256
Lease liability, short term 138,213 134,343
Notes payable, net of debt discount of $21,062 and $23,878, respectively 350,418 297,602
Notes payable, related parties, net of debt discount of $34,826 and $49,473, respectively 1,188,051 990,637
Total current liabilities 5,852,968 5,363,792
Long term liabilities:    
Economic Injury Disaster loan, long term 73,509 73,850
Royalty obligation, net of discount of $5,261,456 and $5,376,790, related parties 3,460,644 3,345,310
Lease liability, long term 145,094 181,328
Deferred revenue, long term 4,045 4,045
Total liabilities 9,536,260 8,968,325
Preferred stock, no par value, 600,000 authorized    
Common stock, $0.001 par value; 750,000,000 shares authorized, 8,102,173 and 7,718,636 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 8,103 7,719
Common stock subscribed 100,000 100,000
Common stock subscription receivable 300,000 0
Additional paid in capital (66,815,130) (66,130,296)
Accumulated deficit (75,345,757) (74,336,105)
Total deficit attributable to BioCorRx Inc. (8,700,908) (8,076,474)
Non-controlling interest (126,191) (125,257)
Total deficit (8,827,099) (8,201,731)
Total liabilities and deficit 709,161 766,594
Series A Convertible Preferred Stock [Member]    
Preferred stock, no par value, 600,000 authorized    
Preferred stock value 16,000 16,000
Series B Convertible Preferred Stock    
Preferred stock, no par value, 600,000 authorized    
Preferred stock value $ 5,616 $ 5,616